Clinical Trials Directory

Trials / Conditions / Salivary Gland Adenoid Cystic Carcinoma

Salivary Gland Adenoid Cystic Carcinoma

5 registered clinical trials studyying Salivary Gland Adenoid Cystic Carcinoma.

StatusTrialSponsorPhase
CompletedAkt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
NCT01604772
National Cancer Institute (NCI)Phase 2
CompletedVorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
NCT01175980
National Cancer Institute (NCI)Phase 2
CompletedDasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
NCT00859937
National Cancer Institute (NCI)Phase 2
CompletedLapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland
NCT00095563
National Cancer Institute (NCI)Phase 2
CompletedBortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Ad
NCT00077428
National Cancer Institute (NCI)Phase 2